Terbutalin Sulphate Nebuliser Solution MA is approved
April 12, Shijiazhuang No. 4 Pharmaceutical Co., Ltd. gained the manufacture and registration approval of Terbutalin Sulfate Nebuliser Solution 2ml: 5mg from NMPA, it is viewed as consistency evaluaiton has been completed.
Terbutalin Sulfate Nebuliser Solution is used for relief bronchospasm associate with bronchial asthma, chronic bronchitis, emphysema and other pulmonary diseases.
It can only be administered though an atomizer, dilution is not in need.
Merck Announces Acquisition of Sigma-Aldrich for $14 Billion
Merck & Co., Germany, announced on Monday that it will acquire Sigma Aldrich Life Sciences for a total of $14 billion per share for a total of $14 billion
National Strategy: China's precision medicine is making big strides forward
At present, the precision medical industry cluster represented by the United States and China and Europe is taking shape.